Journal article

Diverse fibrillar peptides directly bind the Alzheimer's amyloid precursor protein and amyloid precursor-like protein 2 resulting in cellular accumulation

AR White, F Maher, MW Brazier, MF Jobling, J Thyer, LR Stewart, A Thompson, R Gibson, CL Masters, G Multhaup, K Beyreuther, CJ Barrow, SJ Collins, R Cappai

Brain Research | ELSEVIER SCIENCE BV | Published : 2003

Abstract

The Alzheimer's disease Aβ peptide can increase the levels of cell-associated amyloid precursor protein (APP) in vitro. To determine the specificity of this response for Aβ and whether it is related to cytotoxicity, we tested a diverse range of fibrillar peptides including amyloid-β (Aβ), the fibrillar prion peptides PrP106-126 and PrP178-193 and human islet-cell amylin. All these peptides increased the levels of APP and amyloid precursor-like protein 2 (APLP2) in primary cultures of astrocytes and neurons. Specificity was shown by a lack of change to amyloid precursor-like protein 1, τ-1 and cellular prion protein (PrPc) levels. APP and APLP2 levels were elevated only in cultures exposed to..

View full abstract

University of Melbourne Researchers